Two Top Stories of Wall Street: Vector Group Ltd. (NYSE:VGR), Ironwood Pharmaceuticals, Inc. (NASDAQ:IRWD)

Vector Group Ltd. (NYSE:VGR)

The shares of Vector Group Ltd. (NYSE:VGR) started off the last trading session with the price of $20.55 while closing the day with the price of $20.48. The shares of Vector Group Ltd. (NYSE:VGR) Fell -0.34% with the Loss of -0.07 points.

The shares of Vector Group Ltd. (NYSE:VGR) traded with the day volume of 1.63 Million shares whereas its average trading volume is 675.31 Million.

While analyzing the past performance of the stock we can see that the shares of Vector Group Ltd. (NYSE:VGR) Loss -3.31% in the last week while rising 0.89% in the last month. Past quarter performance shows the red light with -10.33%. The semi-annual and annual performance shows -1.9% and 2.99% respectively.

Some critical values of the shares of Vector Group Ltd. (NYSE:VGR) to be discussed here are: the beta which shows the value at 0.45 while Average True Range of Vector Group Ltd. (NYSE:VGR) demonstrate the value at 0.41. The weekly and monthly volatility of the shares of Vector Group Ltd. (NYSE:VGR) are indicated at 1.79% and 1.76%. Also to discuss here is the Relative Strength Index or RSI which is depicted at 46.57.

While studying the financial position of the shares of Vector Group Ltd. (NYSE:VGR), we can see that the Market capitalization of the company is at 2.78 Billion. The shares outstanding for the company is 135.64 Million and the shares float stands at 99.71 Million. The income of the company stand at 49.7 Million while the sales stand at 1.81 Billion.

Here are some critical ratios for a financial perspective: Earnings Per Share or EPS of the company stand at 0.37, Price to Earnings or P/E is at 54.91, Price to Sales P/S show the value of 1.54, the Return on Asset ROA stood at 0.057 and the Return on Equity ROE depicted at -0.206 while Return on Investment ROI is at 0.21.


Ironwood Pharmaceuticals, Inc. (NASDAQ:IRWD)

Ironwood Pharmaceuticals, Inc. (NASDAQ:IRWD) started its previous trading session at $15.43 and closed at $15.36 showing a Fell of -0.45 Percent.

The Company traded with an average Volume of 1.49 Million whereas, its Day Volume stood at 1.62 Million.

Looking at the performance of the stock, Ironwood Pharmaceuticals, Inc. (NASDAQ:IRWD) Gain 0.72% in the last week in its shares price and 6% in the last month. Quarterly performance shows a red of -1.22 Percent while Semi-Annual and Annual performances shows a -4.24 and -13.07 percent respectively.

Beta for Ironwood Pharmaceuticals, Inc. (NASDAQ:IRWD) stands at 1.14 while the ATR (average true range) is at 0.56. The Stock’s Weekly and Monthly Volatility is 3.12% and 3.76% respectively showing a RSI value of 55.94.

While studying the financial position of the shares of Ironwood Pharmaceuticals, Inc. (NASDAQ:IRWD), we can see that the Market capitalization of the company is at 2.31 Billion. The shares outstanding for the company is 150.44 Million and the shares float stands at 135.28 Million.

The Company generated an income of -116900000 and the sales of 298.3 Million in the Trailing Twelve Months period.

While analyzing the stock from technical aspects, Diluted Earnings per share stands at $-0.79 a share. P/E (price to earnings) and P/S (price to sales) values are 0 and 7.75 respectively.

The Return on Assets stands at -0.177, ROE shows a value of 0 and ROI for Ironwood Pharmaceuticals, Inc. (NASDAQ:IRWD) is 0 as of Trailing Twelve Months period.

The following two tabs change content below.

Eldred Matthew

Eldred Matthew covers Healthcare Sector Company recent Press Releases news updates. He has three year of experience in content writing as freelance writer. He performs analysis of Healthcare Companies and provides worthy information for investor community. He is an experienced writer with a precise grasp of the English language and a clear, compelling writing style.

View all contributions by

Eldred Matthew covers Healthcare Sector Company recent Press Releases news updates. He has three year of experience in content writing as freelance writer. He performs analysis of Healthcare Companies and provides worthy information for investor community. He is an experienced writer with a precise grasp of the English language and a clear, compelling writing style.

Leave a Comment